The U.S. Court of Appeals for the Third Circuit has decided that private insurers that provide Medicare benefits have the right to recover, just as the government does, from GlaxoSmithKline for expenses incurred for injuries consumers have suffered by taking the drugmakers Avandia diabetes drug.
Humana Medical Plan Inc., the putative class representative for health insurers who provide health care coverage as Medicare Advantage organizations under Part C of that federal Medicare law, argued that GSK should reimburse such organizations for the benefits they have provided to their insured for Avandia-related injuries. GSK countered that the Medicare law does not provide a private cause of action for Medicare Advantage organizations, according to an opinion issued late last week.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
